Related Articles |
Title/Author
(Click for Abstract / Details / Purchase) |
Issue/Page
View/Buy |
Menopausal Symptom Relief and Side Effects Experienced by Women Using Bioidentical Hormone Replacement Therapy and Synthetic Conjugated Equine Estrogen and/or Progestin Hormone Replacement Therapy, Part 1
Deleruyelle Laura J
|
Sep/Oct 2016
Pg. 359-364
|
Menopausal Symptom Relief and Side Effects Experienced by Women Using Compounded Bioidentical Hormone Replacement Therapy and Synthetic Conjugated Equine Estrogen and/or Progestin Hormone Replacement Therapy, Part 2
Deleruyelle Laura J
|
Nov/Dec 2016
Pg. 447-454
|
A Perspective on HRT for Women: Picking Up the Pieces After the Women's Health Initiative Trial - Part 1
Gillson George R, Zava David T
|
Jul/Aug 2003
Pg. 250-256
|
Efficacy and Tolerability of Compounded Bioidentical Hormone Replacement Therapy
Vigesaa Kristy A, Downhour Nathan P, Chui Michelle A, Cappellini Linda, Musil John D, McCallian Dennis J
|
Jul/Aug 2004
Pg. 313-319
|
Bioidentical Hormone Replacement Therapy, Part 2, A Review of
Wepfer Scott T
|
Jan/Feb 2002
Pg. 50-54
|
Bioidentical Hormone Replacement Therapy, Part 3, A Review of
Wepfer Scott T
|
Mar/Apr 2002
Pg. 142-146
|
Menopausal Symptom Relief and Side Effects Experienced by Women Using Compounded Bioidentical Hormone Replacement Therapy and Synthetic Conjugated Equine Estrogen and/or Progestin Hormone Replacement Therapy, Part 3
Deleruyelle Laura J
|
Jan/Feb 2017
Pg. 6-16
|
Using Serum Hormone Analysis to Develop Hormone Replacement Therapy Regimens - Part 2
Ford Gina, Garcia Lea
|
Jan/Feb 2001
Pg. 52-54
|
Impact of Conventional and Bioidentical Hormone Replacement Therapy on Cardiovascular and Breast Health: A Review
Ruiz Andres D, Daniels Kelly R, Barner Jamie C, Carson John J, Frei Christopher R
|
Jul/Aug 2011
Pg. 290-300
|
Menopausal Women's Access Path to Bioidentical Hormone Replacement Therapy: An Exploratory Study
Moro Doris, Young Wendy, Stein Richard, Isaac Winston, Goodman Deborah
|
Mar/Apr 2010
Pg. 165-170
|
Establishing a Rationale for Compounding Hormone Replacement Therapy
Biundo Bruce
|
May/Jun 2018
Pg. 190-195
|
Establishing a Rationale for Compounding Hormone Replacement Therapy
Biundo Bruce
|
Jan/Feb 2024
Pg. 22-27
|
Patient Interest in Pharmacist-Provided Menopause and Hormone Replacement Therapy Consultations
Branvold Andrea, Barner Jamie C
|
Nov/Dec 2003
Pg. 490-494
|
Natural or Bioidentical Hormone Replacement: What makes the Difference? An Interview with Christopher B. Cutter, MD.
Vail Jane
|
Jan/Feb 2003
Pg. 24-26
|
Guidelines for Consulting with Patients about Bioidentical Hormone Replacement Therapy
White Irene Q
|
Jul/Aug 2005
Pg. 266
|
Efficacy and Clinical Value of Commonly Compounded Hormone Replacement Therapy: A Literature Review
Beshay Sarah M, Rivera Gerard, Balthasar Jan, Florea Naomi
|
Jan/Feb 2015
Pg. 6-12
|
Gender Bias in the Treatment of Menopausal Women: I am Hot as Hell and Not Going to Take It Anymore, Part 1
DeRosa Angela
|
Nov/Dec 2020
Pg. 466-470
|
Book Review: HRT: The Answers. A Concise Guide for Solving the Hormone Replacement Therapy Puzzle
Reed-Kane Dana
|
Nov/Dec 2004
Pg. 412
|
Natural Hormone Replacement Therapy: What It Is and What Consumers Really Want
Reed-Kane Dana
|
Sep/Oct 2001
Pg. 332-335
View Sample |
The Effectiveness of Sublingual and Topical Compounded Bioidentical Hormone Replacement Therapy in Post-menopausal Women: An Observational Cohort Study
Ruiz Andres D, Daniels Kelly R
|
Jan/Feb 2014
Pg. 70-77
|
Bioidentical Hormones in the News
Bramwell Bethany L
|
Sep/Oct 2010
Pg. 374-380
|
The Lived Experience of Perimenopausal and Menopausal Women Undergoing Treatment with Bioidentical Hormones
Holt-Waldo NaRisa Y, Stephenson Kenna
|
Jul/Aug 2007
Pg. 292-296
|
Hormone Therapy: It's Time for a Second Opinion
Collins Joseph J, Ahlgrimm Maria
|
Mar/Apr 2008
Pg. 122-127
|
Natural Progesterone in Natural Hormone Replacement Therapy, The Role of
Girouard Lorinda G, Holm Richard C
|
May/Jun 2001
Pg. 218-220
|
Saliva Tests, Part 2: Salivary Hormones, Hormone Replacement Pharmacokinetics, and the Importance of Timely Testing
Kells John, Dollbaum Charles M
|
Sep/Oct 2009
Pg. 392-399
|
Satisfaction of Patients Using Bioidentical Hormones for Hormone Replacement Therapy
Santoro Filippo
|
Sep/Oct 2002
Pg. 378
|
The Effects of Compounded Bioidentical Transdermal Hormone Therapy on Hemostatic, Inflammatory, and Immune Factors; Cardiovascular Biomarkers; Quality of Life Measures; and Health Outcomes in Perimenopausal and Postmenopausal Women
Stephenson Kenna, Neuenschwander Pierre F, Kurdowska Anna K
|
Jan/Feb 2013
Pg. 74-85
View Sample |
The Science Behind Hormone Replacement Therapy, Part 1
Wepfer Scott T
|
Nov/Dec 2001
Pg. 462-464
|
The Politics of Hormone Replacement Therapy
Allen Loyd V Jr
|
Jul/Aug 2007
Pg. 278-281
|
Patient Satisfaction with Pharmacist Intervention and Consultation in Hormone Replacement Therapy: An Update
Hu Fei-Shu, Reed-Kane Dana, Draugalis JoLaine R
|
May/Jun 2006
Pg. 187-192
|
Hormone Replacement Therapy, Part 2: Estrogen Defined
Lorentzen Jean
|
Nov/Dec 2001
Pg. 460-461
|
Gender Bias in the Treatment of Menopausal Women: I am Hot as Hell and Not Going to Take It Anymore, Part 2
DeRosa Angela
|
Jan/Feb 2021
Pg. 14-17
|
Bilateral Areolar Hyperpigmentation Following Transdermal Administration of Compounded Hormone Replacement Therapy
Griffee Chris, Delano Amy
|
Mar/Apr 2012
Pg. 110-114
|
The Role of Drug Promotion in the Prescription of Hormone Replacement Therapy in the United States
Stephenson Kenna, Jones William, Stephenson Douglas M M
|
May/Jun 2006
Pg. 175-183
|
Patient Handout - Hormone Replacement Therapy
Reed-Kane Dana
|
Sep/Oct 2003
Pg. 339
|
Common Acronyms Used by Health Professionals Who Prescribe or Prepare Hormone Replacement
Price Dared L
|
Jul/Aug 2007
Pg. 288-291
|
The Role of Sex Hormones on Fibromyalgia Pain Mediators
Bramwell Bethany L
|
May/Jun 2010
Pg. 193-199
|
PreScription: Issues with the NAMS 2017 Hormone Therapy Position Statement
Allen Loyd V Jr
|
Nov/Dec 2017
Pg. 444
|
Natural Estrogens: A Review of the Primary Literature
Glasnapp Andrew
|
Mar/Apr 2000
Pg. 110-114
|
Correcting Misconceptions about Compounding Bioidentical Hormones: A Review of the Literature
Paoletti Jim, Kaul Monica, Kloesel Lawson G
|
Jul/Aug 2007
Pg. 269-272
|
Profile of A Practice: Hormone Replacement Therapy in the Heartland
Hudson Sonora
|
Sep/Oct 2000
Pg. 362
|
Estrogen Replacement Therapy in the Treatment of Alzheimer's Disease
Osburn Jennifer
|
May/Jun 2002
Pg. 171-176
|
Using Serum Hormone Analysis to Develop Hormone Replacement Therapy Regimens-Part 1
Ford Gina, Garcia Lea
|
Nov/Dec 2000
Pg. 421-422
|
Hormone Replacement Therapy: Part 1 - The Evolution of Hormone Treatment
Lorentzen Jean
|
Sep/Oct 2001
Pg. 336-338
|
Effect of Penetration Enhancers on the Percuaneous Delivery of Hormone Replacement Actives
Trimble John O, Light Bob
|
Nov/Dec 2017
Pg. 530-535
|
A Perspective on HRT for Women: Picking Up the Pieces After the Women's Health Initiative Trial - Part 2
Gillson George R, Zava David T
|
Sep/Oct 2003
Pg. 330-338
|
Hypothyroidism: Optimizing Therapy with Slow-Release Compounded Thyroid Replacement
Milner Martin
|
Jul/Aug 2005
Pg. 268-273
|
Testosterone Replacement Therapy for Female Androgen Insufficiency Syndrome
Tan Robert S
|
Jul/Aug 2005
Pg. 259-264
View Sample |
"Natural" Isomolecular Hormone Replacement: An Evidence-Based Medicine Approach
Drisko Jeanne A
|
Nov/Dec 2000
Pg. 414-420
|
Emerging Evidence for Androgen Replacement Therapy in Aging Men
Bramwell Bethany L
|
Mar/Apr 2010
Pg. 94-99
|
Bioidentical Thyroid Replacement Therapy in Practice: Delivering a Physiologic T4-T3 Ratio for Improved Patient Outcomes with the Listecki-Snyder Protocol
Snyder Scott, Listecki Robert E
|
Sep/Oct 2012
Pg. 376-380
|
Basics of Compounding with Dilutions and Concentrates
Allen Loyd V Jr
|
Jan/Feb 2017
Pg. 39-45
|
Hormone Replacement Therapy: Selected Recent References
Foy Elizabeth, MacCara Mary E
|
Nov/Dec 2000
Pg. 426-427
|
Book Reviews: Hormone Replacement Therapy
Paoletti James E
|
Sep/Oct 2001
Pg. 356-357
|
The Standardization of Nonsterile Compounding: A Study in Quality Control and Assessment for Hormone Compounding
Wiley TS, Odegard RD, Raden J, Haraldsen JT
|
Mar/Apr 2014
Pg. 162-168
|
Stability of Fagron's Phytobase Cream Compounded with Various Hormones
Wynn Tom, Taylor Sarah, Zander Clark
|
Mar/Apr 2021
Pg. 156-162
|
PreScription: The NASEM cBHT Report, Part 2
Allen Loyd V Jr
|
Jan/Feb 2021
Pg. 4
|
Major Study Affirming the Relative Safety of Testosterone-replacement Therapy
Biundo Bruce
|
Sep/Oct 2023
Pg. 358-360
|
PreScription: The NASEM cBHT Report, Part 1
Allen Loyd V Jr
|
Nov/Dec 2020
Pg. 444
|
Natural Testosterone: Hormone of the Heart
Wright Jonathan V, Lenard Lane
|
Mar/Apr 1999
Pg. 88-98
|
Natural HRT: Corrective Measures When the System Goes Down
Ford Gina
|
Mar/Apr 1999
Pg. 109
|
The Salivary Hormone Profile in the Clinical Evaluation of Women
Stephenson Kenna
|
Nov/Dec 2004
Pg. 427-435
|
The Value of Hormone Assessment
Collins Joseph J
|
Sep/Oct 2001
Pg. 342-344
|
Estradiol: The Emerging Evidence for a Protective Role Against Insulin Resistance and Obesity
Biundo Bruce, Gogola Margaret
|
Jul/Aug 2015
Pg. 289-293
|
Andropause: New Perspectives
Biundo Bruce
|
May/Jun 2004
Pg. 175-178
|
Estrogen Replacement: A Review of Current Literature
Parazewski Kevin
|
Sep/Oct 2001
Pg. 346-350
|
Calculations
Stockton Shelly J, Stover Emily M
|
Nov/Dec 2019
Pg. 484
|
Saliva Tests, Part 1: Clinical Use, Elements of Testing, and Guidelines for Posttreatment Interpretation
Kells John, Dollbaum Charles M
|
Jul/Aug 2009
Pg. 280-288
|
Bioidentical Hormones in the Treatment of Osteoporosis
Boomsma Diane
|
Sep/Oct 2001
Pg. 339-341
|
Treatment Options for Male Hypogonadism
Biundo Bruce
|
Jan/Feb 2013
Pg. 28-38
|
Treatment Options for Male Hypogonadism
Biundo Bruce
|
Jan/Feb 2024
Pg. 6-14
|
FDA-funded Report on Compounded Hormones is Tainted, Analysis Shows
Brunner Scott
|
May/Jun 2021
Pg. 206-209
|
Natural-Product Therapies for Treating Diabetic Neuropathy
Anderson Constance
|
Mar/Apr 2000
Pg. 98-100
|
Patient Satisfaction with Pharmacist Intervention and Consultation in HRT
DiMaggio Jennifer Lyn, Reed-Kane Dana
|
Jul/Aug 2003
Pg. 258-263
|
Sensitization Therapy for Warts
Kuntz Rachael
|
Jul/Aug 2003
Pg. 266-270
|
The Hormonal Link to Breast Cancer: The Estrogen Matrix
Zava David T
|
Jul/Aug 2002
Pg. 250-254
|
Novel Approaches to Topical Psoriasis Therapy
Koyama Gregory, Liu Jenny, Scaffidi Alyse, Khazraee Maryam, Epstein Benjamin
|
Sep/Oct 2015
Pg. 357-365
|
Poster Presentation Report: Safety of Maternal Testosterone Therapy During Breast Feeding
Glaser Rebecca L, Newman Mark, Parsons Melanie, Zava David, Glaser-Garbrick Daniel
|
Jul/Aug 2009
Pg. 314-317
|
Estrogen Use in Dogs: Indications and Complications
Davidson Gigi S
|
Nov/Dec 2000
Pg. 468-470
|
Three Things You Need to Know Right Now
Brunner Scott
|
May/Jun 2022
Pg. 211-213
|
Vulvovaginal Symptoms in a Postmenopausal Woman: A Case Study
Lima Ramona, Gonzalez Mark A, Urwin Craig, Jean Linda, Carvalho Maria, Banov Fabiana
|
Mar/Apr 2023
Pg. 108-112
|
Androgen Deficiency in Women: Understanding the Science, Controversy and Art of Treating Our Patients - Part 1
Cutter Christopher B
|
Jan/Feb 2004
Pg. 16-21
|
PreScription: Bias, NAMS, and HRT
Allen Loyd V Jr
|
Jul/Aug 2007
Pg. 266
|
The Clinical Use of Dehydroepiandrosterone in Postmenopausal Women
Bramwell Bethany L
|
Nov/Dec 2010
Pg. 465-471
|
Estradiol 0.25 mg/g, Estrone 0.25 mg/g, and Estriol 2 mg/g in HRT Cream Base
Allen Loyd V Jr
|
Sep/Oct 2016
Pg. 407
|
Estradiol 0.5-mg, 1-mg, or 2-mg Capsules
Allen Loyd V Jr
|
May/Jun 2013
Pg. 230
|
Estriol: Women's Choice vs. A Manufacturer's Greed
Goodrum Jennifer
|
Jul/Aug 2008
Pg. 286-292
|
Compounding for Endocrine Disorders in Adult Patients
Grajeda Betty Jo, Vail Jane
|
Jul/Aug 2005
Pg. 275-278
|
Subcutaneous Testosterone Anastrozole Therapy in Men: Rationale, Dosing, and Levels on Therapy
Glaser Rebecca L, York Anne E
|
Jul/Aug 2019
Pg. 325-339
|
Effect of Emulsifier Pairs on Physical Stability of Emulsions Containing Three Different Natural Oils
Boonme Prapaporn, Maneenuan Duangkhae
|
Nov/Dec 2014
Pg. 516-519
|
PostScription: Natural Tragedies: Pharmacists are Integral Members of the Emergency Healthcare Team
Williams LaVonn A
|
Jul/Aug 2011
Pg. 350-351
|
Natural Tragedies: Planning for Disasters and Emergencies
Williams LaVonn A
|
Sep/Oct 2011
Pg. 368-371
|
The Compatibility of Common Respiratory Therapy Drug Combinations
Owsley Heather D, Rusho William F
|
Mar/Apr 1997
Pg. 121-122
|
Estrogen in the Treatment and Prevention of Alzheimer's Disease
Paganini-Hill Annlia, Henderson Victor W
|
Jan/Feb 1998
Pg. 24-29
|
Treatment of Skin Aging with Topical Estrogens
Schmidt Jolanta B, Binder Martina, Demschik Gabriele, Bieglmayer Christian, Reiner Angelika
|
Jul/Aug 1998
Pg. 270-275
|
Physical and Chemical Stability of Estriol 0.025% to 1% Vaginal Creams (VersaBase)
Ip Kendice, Shan Ashley, Yan Wei, Banov Daniel
|
Nov/Dec 2018
Pg. 504-511
|
Profile of a Practice
Davis Jeanie Lerche
|
Mar/Apr 1999
Pg. 116-117
|
Natural Progesterone Handout
Kuntz Rachael
|
Jul/Aug 2005
Pg. 281-282
|
Transdermal Progesterone: Effects on Menopausal Symptoms and on Thrombotic, Anticoagulant, and Inflammatory Factors in Postmenopausal Women
Stephenson Kenna, Neuenschwander Pierre F, Kurdowska Anna K, Pinson Barbara, Price Carol
|
Jul/Aug 2008
Pg. 295-304
|
Interview on HRT: Christiane Northrup, MD, FACOG
Allen Loyd V Jr, Northrup Christiane
|
Jan/Feb 1998
Pg. 12-17
|
Profile of a Practice
Davis Jeanie Lerche
|
Mar/Apr 2000
Pg. 120-121
|
Burning Mouth Syndrome: A Discussion of a Complex Pathology
Zur Eyal
|
May/Jun 2012
Pg. 196-205
|
PreScription: The Past (-->2020), The Present, and The Future (2021-->)
Allen Loyd V Jr
|
Mar/Apr 2021
Pg. 92
|
Calculations
Stockton Shelly J, Drinnon Stephen D
|
Jul/Aug 2019
Pg. 312-313
|
Tri-Est, Progesterone, and Testosterone in Versatile, Phytobase, Fitaline, and HRT Supreme Cream Bases
Allen Loyd V Jr
|
May/Jun 2017
Pg. 238
|
A Review of Current Research on the Effects of Progesterone
Boomsma Diane, Jim Paoletti
|
Jul/Aug 2002
Pg. 245-249
|
PostScription: It Is Not Just What You Say…But How You Say It!
Reed-Kane Dana
|
Jul/Aug 2008
Pg. 375
|
PostScription: Women in Balance: A Cause Worth Advancing
Murray Jane, Reilly Colleen
|
Jul/Aug 2005
Pg. 327-328
|
Androgen Deficiency in Women: Understanding the Science, Controversy and Art of Treating Our Patients - Part 2
Cutter Christopher B
|
Mar/Apr 2004
Pg. 96-99
|
Women's Oral Health: Is There a Hormonal Link?
Preckshot John
|
Jan/Feb 2004
Pg. 10-14
|
Calculations
Prince Shelly J
|
Jul/Aug 2005
Pg. 307-308
|
Calculations
Stockton Shelly J
|
Jul/Aug 2008
Pg. 354
|
Estradiol 0.1% Vaginal Solution
Allen Loyd V Jr
|
Sep/Oct 2008
Pg. 450
|
Premarin: The Intriguing History of a Controversial Drug
Vance Dwight A
|
Jul/Aug 2007
Pg. 282-286
|
Hormonal Influences in Prostate Cancer: An Update of a Complex Subject
Biundo Bruce
|
Mar/Apr 2010
Pg. 100-104
|
Calculations
Stockton Shelly J
|
Jul/Aug 2009
Pg. 330
|
The Physiologic Role and Use of Estriol
Paoletti Jim E
|
Jul/Aug 2009
Pg. 270-275
|
The Physiologic Role and Use of Estriol
Paoletti Jim E
|
Jan/Feb 2024
Pg. 16-21
|
Estradiol 0.1% Vaginal Solution
Allen Loyd V Jr
|
Jan/Feb 2024
Pg. 58
|
Clinical Utility of Pharmacogenetic Testing in Compounding Pharmacy
Fichter Brian, Heintzelman Tom, Hurst Sawan, Fitzsimmons Dorothy, Mailloux Christina
|
Nov/Dec 2013
Pg. 452-457
|
Women's Health Book Reviews
Reed-Kane Dana
|
Sep/Oct 1999
Pg. 357-359
|
The History of Progesterone
Newton Stephen J
|
Jul/Aug 2007
Pg. 274-277
|
Progesterone 100-mg, Melatonin 1-mg, and L-Theanine 200-mg Slow-Release Capsules
Allen Loyd V Jr
|
Jan/Feb 2020
Pg. 62
|
Trace Level Analysis of Airborne Hormone Particulates
Trimble John O, Hampton Shanna
|
May/Jun 2018
Pg. 257-263
|
Medical Therapy for Acquired Urinary Incontinence in Dogs
Hill Katie, Jordan Dinah, Ray Jody, Mays Andrew A, Griffin Katie
|
Sep/Oct 2012
Pg. 369-375
|
Hormone Treatment Options for Males: What to Do for Men with Low Testosterone
Biundo Bruce
|
Jul/Aug 2009
Pg. 276-279
|
Wilson's Syndrome and T3 Therapy
Milner Martin
|
Sep/Oct 1999
Pg. 344-348
|
Hormone Treatment Options for Males: What to do for Men with Low Testosterone
Biundo Bruce
|
Jan/Feb 2024
Pg. 28-32
|
The U.S. Food and Drug Administration Takes Aim at Compounded Thyroid Hormone
Brunner Scott
|
Jan/Feb 2023
Pg. 22-23
|
Collaborative Drug Therapy Management and its Application to Pharmaceutical Compounding
Anderson Derick
|
Jan/Feb 2007
Pg. 56-58
|
Case Report: Ketoprofen/Riboflavin/Caffeine Capsules and Progesterone Therapy for Recurrent Migraine Pain
Fields Shannon W
|
May/Jun 2007
Pg. 200
|
Medication Therapy Management Implementation, Part 3: Barriers and Recommendations to Overcome Barriers
Fyke Jeremy P, Yale Robert N, Corbett Corinne, Litera Natalie
|
Nov/Dec 2008
Pg. 508-513
|
Recommendations for Overcoming Barriers to Medication Therapy Management Implementation, Part 1: Review of Literature
Fyke Jeremy P, Yale Robert N, Corbett Corinne, Litera Natalie
|
Jul/Aug 2008
Pg. 329-333
|
Medication Therapy Management Implementation, Part 2: Study Methodologies, Barriers, and Recommendations to Overcome Barriers
Fyke Jeremy P, Yale Robert N, Corbett Corinne, Litera Natalie
|
Sep/Oct 2008
Pg. 414-418
|
Acetaminophen 500-mg and Diphenhydramine Hydrochloride 25-mg Hot Therapy Packs
Allen Loyd V Jr
|
Sep/Oct 2007
Pg. 416
|
Compounded Levofloxacin Triple Therapy is Safe and Effective for Refractory Helicobacter pylori
Mah Xian-Jun, Gupta Vikas, Loch Srey Neth, Ahlenstiel Golo, van de Poorten David
|
Jul/Aug 2017
Pg. 330-333
|
Bioidentical Topical Progesterone: A Survey of Patients
Warren Aileen, Listecki Robert E
|
Sep/Oct 2001
Pg. 354-355
|
Planning and Marketing a Natural HRT Patient Seminar
Trent Kerry Cunningham
|
Sep/Oct 1999
Pg. 360-361
|
Triple Estrogen 2.5-mg, Progesterone 100-mg and Testosterone 1-mg Capsules
Allen Loyd V Jr
|
Sep/Oct 1999
Pg. 400
|
Triple Estrogen 2.5-mg Slow-Release Capsules
Allen Loyd V Jr
|
Sep/Oct 1999
Pg. 401
|
Profile of a Practice: Custom Rx Compounding and Natural Pharmacy
Allen Loyd V Jr
|
Mar/Apr 2001
Pg. 118-119
|
Triple Estrogen 2.5-mg Capsules (Lactose Free)
Allen Loyd V Jr
|
Nov/Dec 1998
Pg. 445
|
Estrogen 0.625-mg/5-g Vaginal Gel
Allen Loyd V Jr
|
Nov/Dec 2000
Pg. 460
|
Triple Estrogen 2.5-mg/0.1-mL PLO
Allen Loyd V Jr
|
Nov/Dec 2000
Pg. 465
|
Triple Estrogen 2.5-mg/0.1-mL Sublingual Drops
Allen Loyd V Jr
|
Nov/Dec 2000
Pg. 466
|
Triple Estrogen 2.5-mg Tablet Triturates
Allen Loyd V Jr
|
Nov/Dec 2000
Pg. 467
|
Estrogen and Breast Cancer: Is There a Link?
Gever Marcy Portnoff
|
Jan/Feb 1998
Pg. 21-23
|
Natural Head Lice Repellant Spray
Allen Loyd V Jr
|
Jan/Feb 2001
Pg. 48
|
Triple Estrogen 2.5-mg in Oil Capsules
Allen Loyd V Jr
|
May/Jun 1997
Pg. 185
|
Triple Estrogen 2.5-mg in Lactose Capsules
Allen Loyd V Jr
|
May/Jun 1997
Pg. 186
|
Triple Estrogen 2.5-mg Semisolid-Filled Hard-Gelatin Capsules
Allen Loyd V Jr
|
May/Jun 1997
Pg. 187
|
Estrogen 0.625-mg/5-g Vaginal Gel
Hinkle Amanda R, Newton Gail D
|
May/Jun 2004
Pg. 185
|
Natural Emollient Oil
Allen Loyd V Jr
|
Nov/Dec 2003
Pg. 462
|
Compounded Orodispersible Films with Natural Ingredients for Halitosis: A Clinical Experience
Apolinário Régis De Souza, Chaves Maria Das Graças Afonso Miranda, Gonçalves Hanny Reis Mockdeci, Martins Isadora Conde Ferreria, De Paula Renée Mazilão, Granato Ana Paula Alves, Polonini Hudson Caetano, Brandão Marcos Antônio Fernandes, Ferreira Anderson De Oliveira, Raposo Nádia Rezende Barbosa
|
Nov/Dec 2018
Pg. 512-515
|
Triple Estrogen 2.5 mg Tablet Triturates
Allen Loyd V Jr
|
Jan/Feb 2024
Pg. 67
|
Natural Head Lice Repellant Spray
Allen Loyd V Jr
|
Jul/Aug 2024
Pg. 312
|
Men's Health: Practical Solutions to a Profoundly Underrated Health-Care Crisis
Milner Martin
|
Mar/Apr 1999
Pg. 76-79
|
Everything Old is New Again
Brunner Scott
|
Jan/Feb 2022
Pg. 30-32
|
Calculations
Stockton Shelly J
|
Jan/Feb 2017
Pg. 58-59
|
Evaluation of Percutaneous Absorption Performance for Human Female Sexual Steroids into Pentravan Cream
Polonini Hudson C, Brandão Marcos Antônio F, Ferreira Anderson O, Ramos Cristiano, Raposo Nádia R B
|
Jul/Aug 2014
Pg. 332-340
|
Testosterone Enanthate 200-mg/mL Injection
Allen Loyd V Jr
|
Mar/Apr 2014
Pg. 151
|
Women's Perspective on Progesterone: A Qualitative Study Conducted in Australia
Spark M Joy, Dunn Rebecca A, Houlahan Kelli L
|
Jul/Aug 2009
Pg. 345-349
|
Transdermals: The Skin as Part of a Drug Delivery System
Allen Loyd V Jr
|
Jul/Aug 2011
Pg. 308-315
|
Testosterone Levels in an Aging Population: Screen, Measure, and Restore
Kells John, DollbaumCharles M
|
Mar/Apr 2011
Pg. 102-112
|
Progesterone 10% Cream
Allen Loyd V Jr
|
Sep/Oct 2016
Pg. 412
|
Calculations
Stockton Shelly J
|
Jul/Aug 2016
Pg. 316-317
|
Compatibility of Estradiol, Estriol, Estrone, Progesterone, and Testosterone Single Formulation in Fitalite, Versatile, or HRT Supreme Cream Base
Polonini Hudson C, Dijkers Eli, Ferreira Anderson O, Zander Clark, Taylor Sarah
|
Jul/Aug 2021
Pg. 336-343
|
Essential Truths About HRT
Everett Lisa, Everett Eric
|
Jan/Feb 1998
Pg. 10-11
|
Profile of a Practice
Hudson Sonora
|
Jul/Aug 2000
Pg. 287
|
Book Reviews: Women's Health
Reed-Kane Dana
|
Nov/Dec 2000
Pg. 424-425
|
Book Review: The Medical & Surgical Practice of NaProTECHNOLOGY
Reed-Kane Dana
|
Jan/Feb 2005
Pg. 5-6
|
Book Reviews: Awakening Athena: Resilience, Restoration, and Rejuvenation for Women
Reed-Kane Dana, Grajeda Betty Jo
|
Jul/Aug 2005
Pg. 252
|
Book Reviews: Perfect Balance
Reed-Kane Dana, Grajeda Betty Jo
|
Jul/Aug 2005
Pg. 253-254
|
PreScription: First Estriol, Then What?
Allen Loyd V Jr
|
Jul/Aug 2008
Pg. 284
|
Progesterone and Traumatic Brain Injury: A Review of Literature
Williams LaVonn A, Mead Jay H
|
Jul/Aug 2008
Pg. 310-315
|
Treating Andropause: Prohormones and Hormone Metabolic Modifiers
Biundo Bruce
|
Sep/Oct 2001
Pg. 351-353
|
Custom-Compounded Micronized Hormones in a Slow-Release Capsule Matrix
Timmons Evelyn D, Timmons Steven P
|
Sep/Oct 2002
Pg. 379
|
Extended Chemical and Microbial Stability of Various Hormones in Phytobase and HRT Heavy Cream Bases
Taylor Sarah, Haselhorst Rodney
|
Jul/Aug 2024
Pg. 344-350
|
Compatibility of Various Hormones in Phytobase and HRT Heavy Cream Bases
Taylor Sarah, Haselhorst Rodney
|
Jan/Feb 2024
Pg. 75-81
|
Combination Therapy of Oral LDN and Topical Pentoxifylline, Rifampin, Clindamycin for Hidradenitis Suppurativa
Bertrand Joe, Bruno Matthew, Komuves Andrew, Jones Nat, Carper Kameryn, Banov Fabiana, Carvalho Maria
|
Jul/Aug 2024
Pg. 271-277
|
Compounded Tirzepatide Therapy for Weight Loss: A Health Economics & Outcomes Research (HEOR) Analysis
Guth Michael AS
|
Jan/Feb 2025
Pg. 52-63
|
Compounding Robots for Intravenous Therapy in European Countries: A Review in 2020
Hecq Jean-Daniel, Soumoy Laura
|
Nov/Dec 2021
Pg. 510-514
|
Minimizing the Risk of Cholesterol-Lowering Therapy
Pratt Sam
|
Sep/Oct 2001
Pg. 362-364
|
Drug Therapy for Acute and Chronic Pain in the Cat
Lascelles B Duncan
|
Sep/Oct 2002
Pg. 338-343
|
Tamoxifen Citrate - A Potential Therapy for the Treatment of Keloids
Glasnapp Andrew
|
Sep/Oct 1999
Pg. 380-381
|
Malathion Topical Lotion: Therapy for Resistant Head Lice
Glasnapp Andrew, Nguyen Linh
|
Jul/Aug 1998
Pg. 268-269
|
Topical Therapy for Localized Hyperhidrosis
Glasnapp Andrew
|
Jan/Feb 2001
Pg. 28-29
|
Submitting Compelling Case Reports for Drug Therapy in Veterinary Patients
Davidson Gigi S
|
Sep/Oct 2007
Pg. 390-395
|
Probiotic Therapy, Part 1: Beneficial Bacteria Improve Health, Save Lives
Vail Jane
|
Mar/Apr 2006
Pg. 107-111
|
Probiotic Therapy, Part 2: Clinical Perspectives
Vail Jane
|
May/Jun 2006
Pg. 195-200
|
Case Report: Transdermal Fluoxetine as Therapy for Feline Anxiety
Fields Shannon W
|
Nov/Dec 2006
Pg. 418
|
Compounding Antiangiogenic Cancer Therapy for Animals
Davidson Gigi S
|
May/Jun 2005
Pg. 195-198
|
Head to Toe Solutions: A Quick Review of Current Therapies
Paoletti James E
|
Sep/Oct 2004
Pg. 345-352
|
Warts: Facts and Therapy (Patient Handout)
Kuntz Rachael
|
Jul/Aug 2004
Pg. 275
|
Low-dose Naltrexone Therapy for Psoriasis
Weinstock Leonard B, Cottel Jill, Aldridge Lindsey, Egeberg Alexander
|
Mar/Apr 2020
Pg. 94-96
|
Extemporaneous Indomethacin Oral Suspension Prepared from Injectable Ampules for Therapy in Premature Infants and Pediatric Patients
de Lafuente Yanina, García Mónica Cristina, Jiminez-Kairuz Alvaro
|
Jul/Aug 2019
Pg. 324-331
|
Low-Dose Naltrexone: A New Therapy Option for Complex Regional Pain Syndrome Type I Patients
Sturn Kayla M, Collin Michael
|
May/Jun 2016
Pg. 197-201
|
Warfarin Personalized Dosage: Re-compounding for a More Suitable Therapy and Better Compliance
Pellagatti Tommaso, Ternelli Marco, Frascio Davide, Bettini Ruggero
|
May/Jun 2017
Pg. 247-250
|
Home Infusion: Available Vascular Access Devices and Common Therapies
Kennedy Steve, Williams LaVonn A
|
May/Jun 2011
Pg. 183-188
|
Compounded Analgesic Therapy for Disorders of Movement: Arthritis, Neuropathic Pain, and Postpolio Syndrome
Brown Scott, Erickson Brian, Muller George, Bryant-Snure Susan J, Mestayer Richard F III
|
May/Jun 2010
Pg. 182-192
|
Ionic Hydration Solution for Anti-Cancer Therapy
Allen Loyd V Jr
|
Mar/Apr 2009
Pg. 156
|
Vitamins: Therapy or Hype
Wynn Tom, Hoffrogge Zach
|
Jan/Feb 2012
Pg. 17-21
|
Evaluation of the Antibacterial Activity of Green Propolis Extract and Meadowsweet Extract Against Staphylococcus aureus Bacteria: Importance in Would Care Compounding Preparations
Lupatini Nogueira Rodrigo José, Danopoulos Panagiota, Swikidisa Rosita, Alves Pinheiro Vanessa
|
Jul/Aug 2016
Pg. 333-337
|
Book Reviews
Reed-Kane Dana
|
Mar/Apr 1999
Pg. 107-108
|
Chemical Stability of Progesterone in Compounded Oral Rapid-dissolving Tablets
Sayre Casey L, Cox Christopher, Velazquez Gabriel, Le Minh Thi, Nguyen Amy Hong, Ramos Marjorie, Burrows Anna, Yellepeddi Venkata Kashyap
|
Jan/Feb 2019
Pg. 62-64
|
Biotechnology, Nanotechnology, and Pharmacogenomics and Pharmaceutical Compounding, Part 2
Allen Loyd V
|
Jul/Aug 2015
Pg. 280-287
|
Compounded Testosterone Troches to optimize Health and the Testosterone Controversy
Guth Michael AS
|
May/Jun 2015
Pg. 195-203
|
Oral Mucositis: Etiology and Clinical and Pharmaceutical Management
Zur Eyal
|
Jan/Feb 2012
Pg. 22-33
|
Testosterone Cypionate 100-mg/mL Injection
Allen Loyd V Jr
|
Jan/Feb 2013
Pg. 73
|
Quality Control: From Record Keeping to Key Performance Indicators: Managing Quality in Compounding Pharmacies
Karime Braga Glaucia, Vieira Fonseca Maria Jose
|
Mar/Apr 2010
Pg. 136-139
|
Male Impotency and the Compounding Pharmacist
Preckshot John
|
Mar/Apr 1999
Pg. 80-83
|
Basics of Pharmacogenomics for the Compounding Pharmacist
Kupiec Thomas C, Raj Vishnu
|
Jul/Aug 2005
Pg. 303-306
|
Sterile Basics: Intravenous Admixture Compounding, Part 1: Introduction and Overview of the General Guidelines for an Intravenous Admixture Compounding Program, and Compounding Personnel Considerations
Allen Loyd V Jr
|
Mar/Apr 2023
Pg. 123-139
|
Compatibility of 17-a-estradiol, Caffeine, Clobetasol Propionate, Finasteride Melatonin, Metronidazole, Spironolactone, Tretinoin, and Triamcinolone in Trichosol, a Natural Vehicle for Hair Solutions
Kegele Carolina Schettino, Marianni Bruna, Polonini Hudson
|
Jan/Feb 2025
Pg. 64-76
|
Pathophysiology and Management of Onychomycosis and Novel Approaches for Effective Transdermal Applications
Dharmian Jose Prakash, Sathiyaseelan Iraniammal, Renganathan Akshaya, Mubees Alamaan Mohamed, Naser Mohammed Yasin Abdul, Ramkrishnan Prakash, Arumugam Somasundaram
|
Nov/Dec 2023
Pg. 494-502
|
Compatibility of Cetirizine Hydrochloride, Dutasteride, Hydrocortisone Acetate, Nicotinamide, Progesterone, and Pyridoxine Hydrochloride in TrichoSolTM, A Natural Vehicle for Hair Solutions
Polonini Hudson C, Taylor Sarah, Silva Carolina C V
|
Sep/Oct 2024
Pg. 440-447
|
Compatibility of Caffeine Clobetasol Propionate Dutasteride Nicotinamide and Progesterone in TrichoFoam™, a Natural Vehicle for Hair Foams
Polonini Hudson C, de Sousa Pamela Lopes, Silva Carolina CV, Marianni Bruna
|
Mar/Apr 2024
Pg. 161-168
|
Differentiation and Treatment of Hypothyroidism, Functional Hypothyroidism, and Functional Metabolism
Paoletti Jim
|
Jan/Feb 2024
Pg. 34-43
|
Levothyroxine Sodium 40-micro-g/mL Oral Liquid
Allen Loyd V Jr
|
May/Jun 2007
Pg. 247
|
Liothyronine Sodium (T3) 5-mcg/0.1-mL Transdermal Cream
Allen Loyd V Jr
|
Nov/Dec 2008
Pg. 546
|
Differentiation and Treatment of Hypothyroidism, Functional Hypothyroidism, and Functional Metabolism
Paoletti Jim
|
Nov/Dec 2008
Pg. 488-497
|
Liothyronine Sodium (T3) 5-mcg/Hydrocortisone 5-mg Slow-Release Capsules
Allen Loyd V Jr
|
Nov/Dec 2008
Pg. 545
|
Liothyronine Sodium (T3) 5-mcg/Selenium 100-mcg Slow-Release Capsules
Allen Loyd V Jr
|
Nov/Dec 2008
Pg. 547
|
Liothyronine Sodium (T3) 5-mcg Slow-Release Capsules
Allen Loyd V Jr
|
Nov/Dec 2008
Pg. 548
|
Lubow's Solution
Allen Loyd V Jr
|
Nov/Dec 2009
Pg. 558
|
Levothyroxine Sodium 100-mcg Capsules
Allen Loyd V Jr
|
Nov/Dec 2013
Pg. 505
|
Solid State Stability of Extemporaneously Prepared Levothyroxine Aliquots and Capsules
Fortner Jeff, Salton Jason, Carlson Christie, Wheeler Rich, Cote Brianna, Rao Deepa
|
Sep/Oct 2015
Pg. 414-419
|
Pharmacists' Perceptions of the Economic Value of Compounded Pharmaceuticals: A Comparison of Compounded and Commercial Pharmaceuticals in Select Disease States
Lobb William B, Wilkin Noel E, Holmes Erin R
|
Nov/Dec 2015
Pg. 514-520
|
Fluoxymesterone 10-mg Capsules
Allen Loyd V Jr
|
Sep/Oct 2017
Pg. 412
|
Kinetic Analysis of Drug Release from Compounded Slow-release Capsules of Liothyronine Sodium (T3)
Bakhteyar Hamid, Cassone Clayton, Kohan Hamed Gilzad, Sani Shabnam N
|
Sep/Oct 2017
Pg. 418-425
|
Estradiol Valerate 40-mg/mL in Oil Injection
Allen Loyd V Jr
|
Nov/Dec 2015
Pg. 509
|
Measuring Testosterone Biomarkers in Serum and Saliva: Are They Accurate?
Tan Robert S
|
Nov/Dec 2004
Pg. 419-423
|
Compounding with Biotechnology Products, Part 2: Product-specific Considerations
Allen Loyd V Jr
|
Nov/Dec 2022
Pg. 446-466
|
Highlighting the Benefits of AlpaWash in Wound Care: Case Reports in Small Animals
Semighini Flavia, Fornaciari Lais de Azevedo, Pinheiro Vanessa, Lupatini Rodrigo, Haiub Halema, Cull Erica, Sidhu Raman
|
Nov/Dec 2023
Pg. 454-460
|
Rheologic Profile, Specific Gravity, Surface Tension, and pH of Fifteen Over-the-Counter Preparations
Al-Achi Antoine, Baghat Tushar, Chukwubeze Onah, Dembla Ishwin
|
May/Jun 2007
Pg. 252-258
|
Proteins Used as Sweeteners
Li Xiaojian, Alexander Kenneth S
|
Nov/Dec 2007
Pg. 476-481
|
Book Reviews
Reed-Kane Dana
|
Jul/Aug 2000
Pg. 288
|
Marketing Tip: PR Can Help with Image Change and Geographic Expansion
Capps Shelly
|
Jul/Aug 1999
Pg. 277
|
Antimicrobial Activity of Copaiba (Copaifera officinalis) and Pracaxi (Pentaclethra macroloba) Oils against Staphylococcus aureus: Importance in Compounding for Wound Care
Guimarães Anna Luísa Aguiar, Cunha Elisa Alves, Matias Fernanda Oliveira, Garcia Patrícia Guedes, Danopoulos Panagiota, Swikidisa Rosita, Pinheiro Vanessa Alves, Nogueira Rodrigo José Lupatini
|
Jan/Feb 2016
Pg. 58-62
|
Practicing Your Compounding Skills Outsides of Your Pharmacy's Walls
Gonzalez Mark
|
May/Jun 2015
Pg. 205-211
|
Stability of Clindamycin Hydrochloride in PCCA Base SuspendIt
Pramar Yashoda V, Graves Richard A, Ledet Grace A, Phan Kelly V, Bostanian Levon A, Mandal Tarun K
|
Sep/Oct 2016
Pg. 421-425
|
Evaluation and Comparison of Wound Healing Properties of an Ointment (AlpaWash) Containing Brazilian Micronized Propolis and Peucedanum ostruthium Leaf Extract in Skin Ulcer in Rats
Nani Marcel, Leone Andréia, Bom Vinícius Pedro, Buszinski Andrei Felipe, Oliveira de Souza Rebeca, Pinheiro Vanessa Alves, Danapoulos Panagiota, Swikidisa Rosita, Marquele-Oliveira Franciane, Cipriani Frade Marco Andrey, Berretta Andresa Aparecida, Nogueira Rodrigo José Lupatini
|
Mar/Apr 2018
Pg. 154-163
|
Insurance Considerations for the Pharmacy Professional
Jones Kirsten
|
May/Jun 2021
Pg. 190-195
|
Considerations for Pharmacists Working in Major Disaster Areas
Kawataba Yoshinori
|
Nov/Dec 2013
Pg. 459-463
|
Clonidine 0.01-mg/mL in Ora-Blend Suspension
Allen Loyd V Jr
|
Sep/Oct 2021
Pg. 414
|
Compounding to Prevent and Treat Dysbiosis of the Human Vaginal Microbiome
Riepl Mike
|
Nov/Dec 2018
Pg. 456-465
|
Andropause: Annotated Citations from the Literature
Biundo Bruce
|
Sep/Oct 1999
Pg. 355-356
|
Calculations
Prince Shelly J
|
Jul/Aug 2002
Pg. 305
|
Case Report: Treatment of Labial Adhesions in a Child
Fields Shannon W
|
Jan/Feb 2007
Pg. 27
|
Current Topical Treatments in Wound Healing - Part 1
Helmke Christopher D
|
Jul/Aug 2004
Pg. 269-274
|
Compounding in the Pharmacy Curriculum: Beyond the Basics
Hinkle Amanda R, Newton Gail D
|
May/Jun 2004
Pg. 181-185
|
A Concise Discussion of Headache Types, Part 2: Migraine
Williams LaVonn A
|
May/Jun 2012
Pg. 182-188
|
Testing of Estradiol in a Compounded Cream and a Stock Solution
Buderer Matthew J, Buderer Nancy M
|
Jan/Feb 2009
Pg. 74-77
|
Glutaraldehyde-treated Autologous Pericardium Used in Valve Repairs
McElhiney Linda F
|
Jan/Feb 2012
Pg. 12-16
|
Home Infusion 101
Williams LaVonn A
|
Jan/Feb 2011
Pg. 6-10
|
Case Report: The Use of Inhaled Cyclosporine to Treat Bronchiolitis Obliterans Syndrome in a Lung Transplant Patient
McElhiney Linda F
|
Mar/Apr 2010
Pg. 112-115
|
Potential Treatments for Radiation Dermatitis
Corsini Lindsay
|
May/Jun 2010
Pg. 210-213
|
PreScription: Changing the Game
Menighan Thomas E
|
Mar/Apr 2010
Pg. 92
|
Quality Control Analytical Methods: Testing of Electrolytes Solutions
Vu Nicole
|
Jan/Feb 2009
Pg. 53-55
|
Gastrointestinal Mucositis: Focus on the Treatment of the Effects of Chemotherapy and Radiotherapy on the Rectum
Zur Eyal
|
Mar/Apr 2012
Pg. 117-124
|
Physiochemical Compatibility of Nebulizable Drug Admixtures Containing Budesonide and Colistmethate or Hypertonic Saline
Klemmer Anja, Krämer Irene, Kamin Wolfgang
|
May/Jun 2013
Pg. 254-261
|
Disguising the Taste of Antiretrovirals for Pediatric Patients Infected with Human Immunodeficiency Virus/Acquired Immunodeficiency Syndrome: Creative Flavor Compounding and Techniques, Part 1
Horace Alexis E, Akbarian-Tefagh Jessica
|
Sep/Oct 2013
Pg. 388-391
|
Colds and Cough
Allen Loyd V Jr
|
Nov/Dec 2012
Pg. 480-483
|
The Role of Compounding in Closing Therapeutic Gaps--Abstracts from FIP 2013
Lutz Eugene, Pauletti Giovanni, Carvalho Maria, Davidson Gigi, Ashworth Lisa, Subramaniam Vaiyapuri, Llambí Francesc
|
Jan/Feb 2014
Pg. 6-12
|
A Brief Survey on Prescriber Beliefs Regarding Compounded Topical Pain Medications
Warner Meredith, Tuder Dmitry
|
May/Jun 2014
Pg. 182-188
|
Roboticized Compounding of Oncology Drugs in a Hospital Pharmacy
Palma Elisabetta, Bufarini Celestino
|
Sep/Oct 2014
Pg. 358-364
|
Topical Treatment of Cutaneous Leishmaniasis in Israel, Part 1
Zur Eyal
|
May/Jun 2019
Pg. 200-207
|
Compounded Cyclophosphamide and Piroxicam for the Treatment of a Canine Peripheral Nerve Sheath Tumor: A Case Report
Pope George, Daleo Charles, Batson SL
|
Sep/Oct 2019
Pg. 358-364
|
Topical Treatment of Cutaneous Leishmaniasis in Israel, Part 3
Zur Eyal
|
Sep/Oct 2019
Pg. 366-375
|
Oral Viscous Sucralfate Gel for Post-procedural Treatment of Barrett's Esophagus
Zur Eyal
|
Sep/Oct 2019
Pg. 376-381
|
Sorafenib Capsules for Pediatric Use
Allen Loyd V Jr
|
Sep/Oct 2019
Pg. 411
|
Compatibility and Stability of VARUBI (Rolapitant) Injectable Emulsion Admixed with Intravenous Palonosetron Hydrochloride Injection and Dexamethasone Sodium Phosphate Injection
Wu George, Powers Dan, Yeung Stanley, Chen Frank
|
Jan/Feb 2018
Pg. 76-85
|
Compatibility and Stability of VARUBI (Rolapitant) Injectable Emulsion Admixed with Intravenous Granisetron Hydrochloride
Wu George, Powers Dan, Yeung Stanley, Chen Frank, Neelon Kelly
|
Jan/Feb 2018
Pg. 86-94
|
The Stanley Prostate-cancer Treatment Protocol for Erectile Dysfunction After Prostatectomy and/or Radiotherapy: A Case Report
McKettrick Greg, Yoch Doug
|
Mar/Apr 2021
Pg. 94-98
|
Basics of Compounding: Excipients Used in Nonsterile Compounding, Part 7: Compounding with Surfactants
Allen Loyd V Jr
|
Sep/Oct 2020
Pg. 388-395
|
Potassium Chloride 1 mmol/mL in Ora-Sweet SF
Allen Loyd V Jr
|
Jan/Feb 2020
Pg. 61
|
Basics of Compounding: 3D Printing--Pharmacy Applications: Geometric Shape Effects on 3D Printing
Allen Loyd V Jr
|
Sep/Oct 2017
Pg. 388-392
|
Betamethasone Valerate 0.12%, Tranilast 1% Topical Gel
Allen Loyd V Jr
|
Sep/Oct 2015
Pg. 405
|
Stability of Diphenhydramine Hydrochloride, Lorazepam, and Dexamethasone Sodium Phosphate in 0.9% Sodium Chloride Stored in Polypropylene Syringes
Anderson Collin R, Halford Zachery, MacKay Mark
|
Jul/Aug 2015
Pg. 344-347
|
Single-Patient Trials, Extemporaneously Compounded Products and Pharmaceutical Care
Fassett William E
|
Nov/Dec 2003
Pg. 441-447
|
ABHR Gel in the Treatment of Nausea and Vomiting in the Hospice Patient
Moon Richard B
|
Mar/Apr 2006
Pg. 95-98
|
Case Report: Treatment of Canine Colitis in a Dachshund with a Compounded Oral Tri-Mix (Green Lizard)
Benischek Rita L, Riffell Gregory S, Mauldin Todd
|
Nov/Dec 2006
Pg. 426-427
|
Granisetron 0.05-mg/mL Oral Suspension
Allen Loyd V Jr
|
May/Jun 2006
Pg. 222
|
Compounded Treatment Options for Cystitis and Other Bladder Problems
McElhiney Linda F
|
Jul/Aug 2006
Pg. 270-275
|
Chemical Stability of Admixtures Combining Ziconotide with Fentanyl or Sufentanil During Simulated Intrathecal Administration
Shields David E, Aclan Jennifer, Szatkowski Aaron
|
Sep/Oct 2008
Pg. 463-466
|
Calculations
Stockton Shelly J
|
Nov/Dec 2008
Pg. 539
|
The Clinical Pharmacist's Role in Compounding for the Diabetic Patient
Harshbarger Robert, Harshbarger Diana
|
Mar/Apr 2000
Pg. 84-87
|
Complications of Diabetes
Key David M
|
Mar/Apr 2000
Pg. 88-90
|
Diabetes Book Reviews
Reed-Kane Dana
|
Mar/Apr 2000
Pg. 103-104
|
The BPS Pharmacy Specialty Certification Program
Bertin Richard J
|
May/Jun 1999
Pg. 200-203
|
Ambulatory Pumps: Part I of a Three-Part Series - Peristaltic Infusion Devices Review
Ashworth Lisa D
|
Jul/Aug 2000
Pg. 281-285
|
Green IV Nutritionals
Karolchyk Scott
|
Jul/Aug 1999
Pg. 260-261
|
Malathion 0.5% Lotion
Allen Loyd V Jr
|
Jul/Aug 1998
Pg. 268-269
|
Warts: Pathophysiology, Types, Treatments, and Pharmaceutical Compounds
Touprong Robin, Thompson Tara, Williams LaVonn A
|
May/Jun 2023
Pg. 182-190
|
Compounding with Biotechnology Products, Part 1: General Considerations
Allen Loyd V Jr
|
Sep/Oct 2022
Pg. 385-395
|
Editorial: Should All Pharmacists Compound?
Allen Loyd V Jr
|
Jan/Feb 2022
Pg. 24-28
|
Calculations
Stockton Shelly J
|
Jan/Feb 2022
Pg. 50
|
Basics of Compounding: Compounding Suppositories: Part I - Theoretical Considerations
Allen Loyd V Jr
|
Jul/Aug 2000
Pg. 289-293
|
Testosterone Deficiency in Men: New Treatments for Andropause
Biundo Bruce, Shippen Eugene
|
Nov/Dec 2000
Pg. 429-431
|
Book and Literature Reviews
Reed-Kane Dana, Foy Elizabeth, MacCara Mary E, MacLean Lindsay
|
Sep/Oct 2004
Pg. 324-327
|
Hydroxyprogesterone Caproate 250-mg/mL-in-Oil Injection
Allen Loyd V Jr
|
Jul/Aug 2003
Pg. 299
|
Oxytocin 10-units/mL Injection
Allen Loyd V
|
Jul/Aug 2015
Pg. 330
|
Evaluation of the Most Frequently Prescribed Extemporaneously Compounded Veterinary Medications at a Large Independent Community Pharmacy
Karara Adel H, Hines Ryan, Demir Zehra, Nnorom Bethran, Horsey Robert, Twigg Geoffrey
|
Nov/Dec 2016
Pg. 461-467
|
Melatonin 2-mg/mL Oral Suspension
Allen Loyd V Jr
|
Nov/Dec 2016
Pg. 512
|
A Pilot Stability Study of Dehydroepiandrosterone Rapid-dissolving Tablets Prepared by Extemporaneous Compounding
Rush Steven D, Vernak Charlene, Zhao Fang
|
Jan/Feb 2017
Pg. 83-87
|
Glutamine 250 mg/mL in SyrSpend SF pH4 Oral Suspension
Allen Loyd V Jr
|
Jan/Feb 2020
Pg. 55
|
Compounding for Patients with Polycystic Ovarian Syndrome (Stein-Leventhal Syndrome)
Riepl Mike
|
May/Jun 2019
Pg. 192-199
|
Physicochemical and Microbiological Stabilities of Hydrocortisone in InOrpha Suspending Agent Studied Under Various Condition
Bourget Philippe, Amin Alexandre, Vidal Fabrice, Pieyre Manon, Dosso El Ourmar, Beauvais Raphaelle, Loeuillet Richard
|
Sep/Oct 2014
Pg. 427-431
|
In Vitro Skin Penetration and Skin Content of Progesterone from Various Topical Formulations
Heustess Allie, Asbill Scott, Eagerton David, Arnold John
|
Nov/Dec 2014
Pg. 512-515
|
Vasopressin 20-units/mL Injection
Allen Loyd V Jr
|
Jan/Feb 2014
Pg. 69
|
Mecasermin 10-mg/mL Injection
Allen Loyd V Jr
|
Mar/Apr 2014
Pg. 144
|
Adrenal Fatigue
Allen Loyd V Jr
|
Jan/Feb 2013
Pg. 39-44
|
Desmopressin 4-mcg/mL Injection
Allen Loyd V Jr
|
Jan/Feb 2013
Pg. 64
|
Octreotide 50-mcg/mL Injection
Allen Loyd V Jr
|
Jan/Feb 2013
Pg. 72
|
Preventing Nonmicrobiologic Airborne Contamination in the Compounding Pharmacy: Ensuring a Safe Environment for Compounders, Staff, and Clients
Mixon Bill, Ille Gary
|
Jul/Aug 2009
Pg. 290-294
|
Low Testosterone in Older Men: A Discussion and Review of Literature on Health Consequences of Hypogonadism in the Aging Male
Biundo Bruce
|
Nov/Dec 2009
Pg. 494-496
|
Thyroid Potency Calculations
Stack Bob
|
Jul/Aug 2010
Pg. 306-309
|
Melatonin 1-mg/mL Oral Suspension
Allen Loyd V Jr
|
May/Jun 2011
Pg. 246
|
Compounding In Crisis:The Aftermath of Hurricane Katrina
Vail Jane
|
Jan/Feb 2007
Pg. 28-35
|
Return to Top |